Virax Biolabs Group Limited (VRAX)

Virax Biolabs Group Revenue

In the fiscal year ending March 31, 2025, Virax Biolabs Group had annual revenue of $6.33K, down -95.95%. Virax Biolabs Group had revenue of $1.38K in the half year ending March 31, 2025, a decrease of -50.80%.

• Revenue (ttm): $6.33K
• Revenue Growth: -95.95%
• P/S Ratio: 521.23
• Revenue / Employee: $333
• Employees: 19
• Market Cap: 3.30M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	6.33K	-150.09K	-95.95%
Mar 31, 2024	156.42K	147.86K	1,727.11%
Mar 31, 2023	8.56K	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	123.82K	23.94K	23.97%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.